戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 the membrane-active cyclopeptide antibiotic, gramicidin S.
2 the membrane-active cyclopeptide antibiotic, gramicidin S.
3 incorporated into the decapeptide antibiotic gramicidin S.
4 llowed by cyclization to form the antibiotic gramicidin S.
5  structural perturbations relative to native gramicidin S.
6 cluding derivatives of cyclosomatostatin and gramicidin S.
7 for the two charge states of the decapeptide Gramicidin S.
8            Particles containing the peptides gramicidin S and gramicidin D were analyzed both with an
9 obic moments for two antimicrobial peptides, gramicidin S and PGLa, under different conditions.
10 osynthesize the symmetric cyclic decapeptide gramicidin S and the cyclic lipoheptapeptide surfactin A
11 clization of a decapeptide thioester to form gramicidin S, and the TE domain from the surfactin NRPS
12 trated using model peptide ions (bradykinin, gramicidin S, and trpzip 1).
13 nd 14 zmol (approximately 8400 molecules) of gramicidin S are reported.
14 enzymatic synthesis of the cyclic antibiotic gramicidin S by gramicidin S synthetase.
15 generation of the D-Phe-S-enzyme that starts gramicidin S chain growth.
16 ale the membrane affinity of the decapeptide Gramicidin S cyclo(d-Phe-Pro-Val-Orn-Leu-)2 (GS).
17 ly protonated substance P, doubly protonated gramicidin S, doubly protonated neurotensin, and triply
18  previously, dications of the cyclic peptide Gramicidin S (GS) and the photoactive organonometallic c
19                          The multifunctional gramicidin S (GS) was the most potent, compared to the m
20           Physisorption of a cyclic peptide, Gramicidin S (GS), was studied for 8 h during deposition
21 drugs, applied here to the cyclic antibiotic gramicidin S, historically limited to topical use due to
22 on also was observed with the cyclic peptide gramicidin S, indicating the generality of the mechanism
23 l synthesis of the cyclic peptide antibiotic gramicidin S is accomplished by two large multifunctiona
24                  The detection of 14 zmol of gramicidin S is to the best of our knowledge a record in
25 mounts of model peptides HLGLAR (m/z 666.8), gramicidin S (m/z 1142.5), and bovine insulin b chain (m
26 cyclization activity: the TE domain from the gramicidin S NRPS catalyzes head-to-tail cyclization of
27 n, cephalosporins, streptomycin, fosfomycin, gramicidin S, rapamycin, indolmycin, microcin B17, fumag
28 tion of DPD with viral DNA or the antibiotic gramicidin S resulted in significant biochemical alterat
29 f the nonribosomal peptide synthetase enzyme gramicidin S synthetase A (GrsA-PheA) for a set of nonco
30 tion module PheATE (GrsA) of Bacillus brevis gramicidin S synthetase catalyzes the activation, thiola
31 n (ATE) initiation module of Bacillus brevis gramicidin S synthetase equilibrates the Calpha configur
32 c transformations is quantified, and how the gramicidin S synthetase I A-domain utilizes its inherent
33 nergy transfer, we show that the A-domain of gramicidin S synthetase I adopts structurally extended a
34                                          The gramicidin S synthetase initiation module (PheATE) is a
35 sis of the cyclic antibiotic gramicidin S by gramicidin S synthetase.
36 nt enhancement to the safety and efficacy of gramicidin S to date, enabling potential systemic MRSA t
37 sheet antimicrobial peptide analogs based on gramicidin S were designed and synthesized.
38 ion modes including rufomycin, colistin, and gramicidin S with comparable success.